Case Report: Hyperinflammatory Status in an Immunocompromised Child With a Highly Sustained Viral Load of SARS-CoV-2

Matias Moragas1, Sandra Gomez2, María Florencia Fernández1

  • 1Unidad de Virología y Epidemiología Molecular - CONICET, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos Aires, Argentina.

Frontiers in Medicine
|September 7, 2021
PubMed

Insights

This case study details a pediatric patient with acute myeloid leukemia who experienced a severe COVID-19 illness with a sustained high viral load and hyperinflammation. The findings highlight unique challenges in managing SARS-CoV-2 in immunocompromised children.

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • Immunology

Background:

  • Limited data exist on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load dynamics in immunocompromised pediatric patients.
  • Understanding these dynamics is crucial for managing Coronavirus disease 2019 (COVID-19) in vulnerable children.

Observation:

  • A pediatric patient with acute myeloid leukemia presented with a unique hyperinflammatory status mimicking MIS-C during COVID-19 infection.
  • The patient exhibited a sustained high SARS-CoV-2 viral load (approx. 7 log10 RNA copies/mL) for six weeks.
  • Hyperinflammation developed early, coinciding with high viral load and immunocompromised status.

Findings:

  • The clinical course involved late-onset fever, gastrointestinal symptoms, rash, and respiratory distress requiring oxygen.
  • This case presents a unique combination of sustained high SARS-CoV-2 viral load, hyperinflammation, and an immunocompromised state in a pediatric oncology patient.
  • The dynamics of SARS-CoV-2 viral load in immunosuppressed children remain largely unreported.

Implications:

  • This case underscores the need for further research into COVID-19 in immunocompromised pediatric populations.
  • Clinical management strategies may need to be adapted for pediatric patients with cancer and SARS-CoV-2 infection.
  • Further studies are warranted to elucidate the interplay between immunosuppression, viral load, and hyperinflammation in pediatric COVID-19.

Related Concept Videos